Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 187 participants.

Also called NCT01505790

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 187 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01505790
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01505790. Randomized; no masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2012-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
Condition
Acute Coronary Syndromes
Intervention (Drug)
PRASUGREL
Intervention (Drug)
Clopidogrel
Lead sponsor
Assistance Publique Hopitaux De Marseille (class: other)

Record details

Record id
cardio:ct-nct01505790
Content hash
5db70b76afb9657190baf959a26a5c8a8113c128613ce6ee9364fdd20117e037